Breaking News Instant updates and real-time market news.

2016-10-14 07:05:06 FB Facebook $127.82 / -1.23 (-0.95%) 07:05 10/14/16 10/14 07:05 10/14/16 07:05	Piper's teen survey shows declining Facebook engagement Piper Jaffray analyst Gene Munster says his firm's latest survey of over 10,000 teens shows Facebook engagement is decreasing. Engagement in the Fall survey is 52% versus 60% in Spring. Factoring out shifts in the population surveyed, core Facebook usage likely declined by three basis points, which indicates Facebook is gradually becoming less relevant versus Instagram and Snapchat, Munster tells investors in a research note. He points out, however, that teens indicating they use Instagram increased five points in the Fall 2016 survey, slightly faster than Snapchat's four points. Desire for engagement from brands on Instagram will drive long-term monetization above core Facebook levels, Munster contends, while noting that declining Facebook usage is a negative. The analyst keeps an Overweight rating on the shares with a $185 price target.	23 Oct 02 Nov 14 Nov
FB Facebook $127.82 / -1.23 (-0.95%) 10/13/16 Loop Capital Facebook keeps expanding addressable market, says Loop Capital 10/11/16 Needham Needham raising Facebook estimates ahead of results 10/10/16 Wells Fargo Alphabet, Facebook can meet Street estimates, says Wells Fargo 10/04/16 Piper Sandler Facebook issues at Marketplace launch a 'non-event,' says Piper Jaffray

2016-10-14 07:05:06

Facebook

$127.82 / -1.23 (-0.95%)

07:05

10/14/16

10/14

07:05

10/14/16

07:05

Piper's teen survey shows declining Facebook engagement

Piper Jaffray analyst Gene Munster says his firm's latest survey of over 10,000 teens shows Facebook engagement is decreasing. Engagement in the Fall survey is 52% versus 60% in Spring. Factoring out shifts in the population surveyed, core Facebook usage likely declined by three basis points, which indicates Facebook is gradually becoming less relevant versus Instagram and Snapchat, Munster tells investors in a research note. He points out, however, that teens indicating they use Instagram increased five points in the Fall 2016 survey, slightly faster than Snapchat's four points. Desire for engagement from brands on Instagram will drive long-term monetization above core Facebook levels, Munster contends, while noting that declining Facebook usage is a negative. The analyst keeps an Overweight rating on the shares with a $185 price target.

23
Oct
02
Nov
14
Nov

FB Facebook

$127.82 / -1.23 (-0.95%)

10/13/16 Loop Capital: Facebook keeps expanding addressable market, says Loop Capital

10/11/16 Needham: Needham raising Facebook estimates ahead of results

10/10/16 Wells Fargo: Alphabet, Facebook can meet Street estimates, says Wells Fargo

10/04/16 Piper Sandler: Facebook issues at Marketplace launch a 'non-event,' says Piper Jaffray

TODAY'S FREE FLY STORIES

Initiation	Needham starts Amwell at Hold, sees limited near-term upside » 09:39 04/15/21 04/15 09:39 04/15/21 09:39 AMWL Amwell $17.20 / +0.24 (+1.42%) Needham analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AMWL Amwell $17.20 / +0.24 (+1.42%) 03/25/21 Amwell falls -14.5% 01/27/21 American Well Corp trading resumes 01/27/21 American Well Corp trading halted, volatility trading pause 01/22/21 Amwell CFO sells over 222,000 class A common shares AMWL Amwell $17.20 / +0.24 (+1.42%) 06:26 Today Needham Amwell initiated with a Hold at Needham 03/25/21 Cowen Amwell price target lowered to $35 from $41 at Cowen 03/25/21 Piper Sandler Amwell price target lowered to $30 from $45 at Piper Sandler 03/23/21 Piper Sandler Piper remains buyer of telehealth companies despite Amazon competition AMWL Amwell $17.20 / +0.24 (+1.42%) 03/24/21 Amwell reports Q4 revenue $60.4M, consensus $54M 03/24/21 Notable companies reporting after market close 11/12/20 Amwell sees FY20 revenue $235M-$239, consensus $231.74M 11/12/20 Amwell reports Q3 EPS (92c), consensus (28c) 15 Jan 17 Sep AMWL Amwell $17.20 / +0.24 (+1.42%) 03/25/21 Fly Intel: Pre-market Movers 03/17/21 Teladoc under pressure as Amazon announces virtual care expansion plans 12/16/20 Teladoc slides on report of Amazon building telehealth business 11/13/20 Fly Intel: Wall Street's top stories for Friday 05/24/21 Global Healthcare Virtual Conference 2021 05/12/21 Amwell - AMWL AMWL Amwell $17.20 / +0.24 (+1.42%) 04/09/21 American Well Corp call volume above normal and directionally bullish 03/24/21 American Well Corp options imply 12.3% move in share price post-earnings 12/15/20 American Well Corp put volume heavy and directionally bearish
Conference/Events	Canaccord to hold a virtual conference » 09:39 04/15/21 04/15 09:39 04/15/21 09:39 ONCY Oncolytics $3.06 / -0.08 (-2.55%) , SESN Sesen Bio $2.35 / +0.015 (+0.64%) , OLMA Olema Oncology $35.84 / +3.56 (+11.03%) , SQZ SQZ Biotechnologies $13.06 / -0.12 (-0.91%) , APTO Aptose Biosciences $5.20 / +0.09 (+1.76%) , BCEL Atreca $12.42 / +0.83 (+7.16%) , BNTX BioNTech $132.52 / +3.11 (+2.40%) Horizons in Oncology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ONCY SESN OLMA SQZ APTO BNTX ONCY Oncolytics $3.06 / -0.08 (-2.55%) 04/12/21 Oncolytics presents preclinical data on pelareorep at AACR 04/12/21 Oncolytics, SOLTI achieve primary endpoint in AWARE-1 study 02/23/21 Oncolytics announces publication of data from pelareorep and CAR T cells study 12/09/20 Oncolytics, SOLTI report data from AWARE-1 study of pelareorep SESN Sesen Bio $2.35 / +0.015 (+0.64%) 04/07/21 Sesen Bio says independent proxy firms recommend voting for proposal 03/22/21 Sesen Bio, Qilu Pharmaceutical announce approval of Vicineum IND in China 03/08/21 Sesen Bio submits MAA to EMA for Vicineum 02/16/21 Sesen Bio announces FDA acceptance/priority review of Vicineum BLA OLMA Olema Oncology $35.84 / +3.56 (+11.03%) 04/06/21 Olema Oncology appoints Yi Larson to board of directors SQZ SQZ Biotechnologies $13.06 / -0.12 (-0.91%) 04/11/21 SQZ presents preclinical data on mRNA-based eAPCs, potential applicability 02/12/21 SQZ Biotechnologies falls -16.3% 02/12/21 SQZ Biotechnologies falls -13.1% 02/12/21 SQZ Biotechnologies falls -14.6% APTO Aptose Biosciences $5.20 / +0.09 (+1.76%) 03/16/21 Aptose Biosciences appoints George Melko as VP, regulatory affairs 10/19/20 Aptose Biosciences initiates dosing of CG-806 in patients with AML BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/13/21 Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/01/21 Pfizer, BioNTech: Vaccine more than 91% effective after 6 months in study 03/31/21 BioNTech, Pfizer: 'Positive' results of COVID-19 vaccine study in adolescents ONCY SESN OLMA SQZ APTO BCEL BNTX ONCY Oncolytics $3.06 / -0.08 (-2.55%) 02/17/21 H.C. Wainwright Oncolytics initiated with a Buy at H.C. Wainwright 05/11/20 RBC Capital Oncolytics price target lowered to C$6 from C$9 at RBC Capital SESN Sesen Bio $2.35 / +0.015 (+0.64%) 02/17/21 Canaccord Sesen Bio price target raised to $7 from $5 at Canaccord 02/16/21 Canaccord Sesen Bio price target raised to $7 from $5 at Canaccord 02/16/21 Jefferies Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario' 01/25/21 Canaccord Sesen Bio a must-own small cap for 2021, says Canaccord OLMA Olema Oncology $35.84 / +3.56 (+11.03%) 12/14/20 JPMorgan Olema Oncology initiated with an Overweight at JPMorgan 12/14/20 Jefferies Olema Pharmaceuticals initiated with a Buy at Jefferies 12/14/20 Canaccord Olema Pharmaceuticals initiated with a Buy at Canaccord 12/14/20 Cowen Olema Pharmaceuticals initiated with an Outperform at Cowen SQZ SQZ Biotechnologies $13.06 / -0.12 (-0.91%) 03/30/21 Brookline SQZ Biotechnologies initiated with a Buy at Brookline 01/07/21 Evercore ISI SQZ Biotechnologies initiated with an Outperform at Evercore ISI 11/24/20 Stifel SQZ Biotechnologies initiated with a Buy at Stifel 11/24/20 BofA SQZ Biotechnologies initiated with a Buy at BofA APTO Aptose Biosciences $5.20 / +0.09 (+1.76%) 02/22/21 JonesTrading Aptose Biosciences resumed with a Buy at JonesTrading 10/19/20 Cantor Fitzgerald Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald 09/22/20 Alliance Global Partners Aptose Biosciences initiated with a Buy at Alliance Global Partners 09/18/20 Piper Sandler Piper Sandler lays out next potential takeover targets in oncology BCEL Atreca $12.42 / +0.83 (+7.16%) 02/08/21 Jefferies Atreca initiated with a Buy at Jefferies 08/12/20 Stifel Volatility in Atreca shares creates 'interesting' opportunity, says Stifel 07/08/20 Piper Sandler Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler 07/01/20 Canaccord Atreca price target raised to $33 from $23 at Canaccord BNTX BioNTech $132.52 / +3.11 (+2.40%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley ONCY SESN OLMA APTO BCEL ONCY Oncolytics $3.06 / -0.08 (-2.55%) 10/27/20 Oncolytics announces new GI cancer study using SESN Sesen Bio $2.35 / +0.015 (+0.64%) 03/15/21 Sesen Bio reports Q4 EPS (11c), consensus (11c) 11/09/20 Sesen Bio reports Q3 EPS (19c), consensus (8c) OLMA Olema Oncology $35.84 / +3.56 (+11.03%) 03/17/21 Olema Oncology reports Q4 EPS (50c), consensus (18c) APTO Aptose Biosciences $5.20 / +0.09 (+1.76%) 03/23/21 Aptose Biosciences reports Q4 EPS (17c), consensus (14c) BCEL Atreca $12.42 / +0.83 (+7.16%) 02/25/21 Atreca reports Q4 EPS (63c), consensus (64c) 11/12/20 Atreca reports Q3 EPS (66c), consensus (61c) 12 Feb 19 Nov 30 Oct 23 Jul 16 Jul 16 Jul BNTX BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says SESN OLMA SQZ APTO BNTX SESN Sesen Bio $2.35 / +0.015 (+0.64%) 03/15/21 Fly Intel: Pre-market Movers OLMA Olema Oncology $35.84 / +3.56 (+11.03%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO SQZ SQZ Biotechnologies $13.06 / -0.12 (-0.91%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut APTO Aptose Biosciences $5.20 / +0.09 (+1.76%) 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/24/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $132.52 / +3.11 (+2.40%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Horizons in Oncology Virtual Conference 05/24/21 Global Healthcare Virtual Conference 2021 05/10/21 BioNTech - BNTX 08/18/21 PDUFA Date for Vicineum 04/22/21 SQZ Biotechnologies 05/03/21 Sesen Bio, Inc. OLMA BNTX OLMA Olema Oncology $35.84 / +3.56 (+11.03%) 03/24/21 new option listings on March 24th BNTX BioNTech $132.52 / +3.11 (+2.40%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names
Initiation	Needham starts Accolade at Buy, sees engagement driving share gains » 09:38 04/15/21 04/15 09:38 04/15/21 09:38 ACCD Accolade $46.64 / -1.2 (-2.51%) As previously Needham… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACCD Accolade $46.64 / -1.2 (-2.51%) 03/04/21 Accolade completes acquisition of 2nd.MD 01/14/21 Accolade jumps almost 13% after announcing acquiring 2nd.MD 01/14/21 Accolade confirms to acquire 2nd.MD for $460M ACCD Accolade $46.64 / -1.2 (-2.51%) 06:24 Today Needham Accolade initiated with a Buy at Needham 03/30/21 Piper Sandler Accolade recent volatility a buying opportunity, says Piper Sandler 03/18/21 Canaccord Accolade price target raised to $62 from $59 at Canaccord 03/11/21 Goldman Sachs Accolade reinstated with a Buy at Goldman Sachs ACCD Accolade $46.64 / -1.2 (-2.51%) 03/23/21 Accolade sees Q4 adjusted EBITDA 60c-$2.10 01/07/21 Accolade sees FY21 revenue $162M-$165M, consensus $159.78M 01/07/21 Accolade sees Q4 revenue $51M-$54M, consensus $51.6M 01/07/21 Accolade reports Q3 EPS (32c), consensus (35c) 22 Oct 02 Jul ACCD Accolade $46.64 / -1.2 (-2.51%) 01/14/21 Accolade to acquire telemedicine start-up 2nd.MD for about $460M, CNBC says ACCD Accolade $46.64 / -1.2 (-2.51%) 03/23/21 Fly Intel: After-Hours Movers 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street ACCD Accolade $46.64 / -1.2 (-2.51%) 01/07/21 Accolade options imply 13.4% move in share price post-earnings
Hot Stocks	Bank of America expects card losses to be lower in Q2 » 09:36 04/15/21 04/15 09:36 04/15/21 09:36 BAC Bank of America $39.90 / +0.59 (+1.50%) Says "plenty of room… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BAC Bank of America $39.90 / +0.59 (+1.50%) 09:16 Today Bank of America sees 'significant decline' in expenses in Q2 09:10 Today Bank of America says customers continue to increase business across platform 06:14 Today Bank of America CFO says 'we saw strong growth in our capital markets' 06:11 Today Bank of America reports book value per share up 4% to $29.07 BAC Bank of America $39.90 / +0.59 (+1.50%) 04/09/21 Jefferies Bank of America price target raised to $41 from $33 at Jefferies 04/07/21 Barclays Bank of America price target raised to $45 from $40 at Barclays 04/05/21 Cowen Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen 04/01/21 Deutsche Bank Bank of America price target raised to $44 from $35 at Deutsche Bank BAC Bank of America $39.90 / +0.59 (+1.50%) 06:05 Today Bank of America reports Q1 EPS 86c, consensus 66c 04/14/21 Notable companies reporting before tomorrow's open 04/14/21 Fly Intel: What to watch in next round of big bank earnings reports 04/14/21 Notable companies reporting before tomorrow's open BAC Bank of America $39.90 / +0.59 (+1.50%) 02/26/21 BofA, JPMorgan give U.S. employees PTO for COVID-19 vaccinations, Reuters says 02/20/21 Bank stocks still have room to run, Barron's says 02/15/21 Citi, Bank of America cut CEO pay, WSJ reports 01/22/21 Bank of America to pay bonuses for work during the pandemic, CNBC reports BAC Bank of America $39.90 / +0.59 (+1.50%) 08:59 Today Fly Intel: Pre-market Movers 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 09:00 Today Bank of America - BAC 04/20/21 Bank of America Corporation BAC Bank of America $39.90 / +0.59 (+1.50%) 04/05/21 Unusual call flow in option market yesterday 04/01/21 Size call spread adjustment in Bank of America 03/26/21 Unusually active option classes on open March 26th 03/19/21 Unusually active option classes on open March 19th
Hot Stocks	Senmiao Technology enters joint operation agreement with Hefei Cheyun » 09:32 04/15/21 04/15 09:32 04/15/21 09:32 AIHS Senmiao Technology $1.41 / -0.03 (-2.08%) Senmiao Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News AIHS Senmiao Technology $1.41 / -0.03 (-2.08%) 04/12/21 Senmiao Technology signs framework agreement with Taoyun Capital 02/25/21 Senmiao Technology places new order for 200 electric vehicles 02/05/21 Senmiao Technology expands cooperation with Chinese e-commerce platform 02/01/21 Senmiao and Chengdu sign stratecgi cooperation agreement

Upgrade	Tapestry upgraded to Positive from Mixed at OTR Global » 09:32 04/15/21 04/15 09:32 04/15/21 09:32 TPR Tapestry / + OTR Global analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TPR Tapestry / + 06:50 Today Tapestry names Todd Kahn as CEO, Brand President of Coach 03/04/21 Tapestry's Kate Spade announces new structure for creative organization 02/04/21 Tapestry sees increase in demand for key categories as vaccine rollout continues 02/04/21 Tapestry sees Covid-related headwinds persisting in near-term TPR Tapestry / + 04/07/21 Piper Sandler Tapestry price target raised to $54 from $45 at Piper Sandler 03/05/21 BMO Capital Tapestry price target raised to $45 from $36 at BMO Capital 02/22/21 Credit Suisse Tapestry upgraded to Outperform with $50 target at Credit Suisse 02/22/21 Credit Suisse Tapestry upgraded to Outperform from Neutral at Credit Suisse TPR Tapestry / + 02/04/21 Tapestry sees FY21 revenue growth in high-single digits, consensus $5.3B 02/04/21 Tapestry reports Q2 non-GAAP EPS $1.15, consensus $1.01 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open TPR Tapestry / + 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/04/21 Fly Intel: Pre-market Movers 11/16/20 Verizon resumption, Tapestry upgrade among today's top calls on Wall Street TPR Tapestry / + 02/25/21 Tapestry put volume heavy and directionally bearish 11/30/20 Tapestry put volume heavy and directionally bearish 10/19/20 Tapestry call volume above normal and directionally bullish
Upgrade	Capri Holdings upgraded to Positive from Mixed at OTR Global » 09:32 04/15/21 04/15 09:32 04/15/21 09:32 CPRI Capri Holdings $52.49 / -0.31 (-0.59%) OTR Global analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 03/02/21 Capri Holdings appoints Alejandro Martinez-Galindo as CIO 02/03/21 Capri Holdings sees lower Q4 revenue than previously expected 01/07/21 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 01/06/21 Celsius Holdings confirms addition to S&P SmallCap 600 Index, effective Jan. 7 CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 03/23/21 Wells Fargo Capri Holdings price target raised to $65 from $60 at Wells Fargo 03/15/21 Piper Sandler Capri Holdings price target raised to $63 from $58 at Piper Sandler 02/04/21 Capri Holdings price target raised to $52 from $50 at Barclays 01/29/21 Baird Capri upgraded to Outperform on multi-year recovery at Baird CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 02/03/21 Capri Holdings reports Q3 adjusted EPS $1.65, consensus $1.01 11/05/20 Capri Holdings sees Q3 sales down double digits, consensus $1.27B 11/05/20 Capri Holdings sees FY sales down approximately 30%, consensus $3.79B 11/05/20 Capri Holdings not providing earnings guidance for FY21 CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 10/26/20 Hedgeye adds Capri Holdings to best ideas list, Bloomberg says CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 12/31/20 Fly Intel: Pre-market Movers 12/30/20 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street CPRI Capri Holdings $52.49 / -0.31 (-0.59%) 02/10/21 Capri Holdings put volume heavy and directionally bearish 02/08/21 Capri Holdings put volume heavy and directionally bearish 01/29/21 Capri Holdings put volume heavy and directionally bearish 01/27/21 Capri Holdings put volume heavy and directionally bearish
General news	March manufacturing output up 2.7%, consensus 3.6% 09:30 04/15/21 04/15 09:30 04/15/21 09:30 $ECON Economic Data / + ShowHide Related Items >><<
General news	March capacity utilization rate up 74.4%, consensus 75.7% 09:30 04/15/21 04/15 09:30 04/15/21 09:30 $ECON Economic Data / + ShowHide Related Items >><<
General news	March industrial production up 1.4%, consensus 2.8% 09:30 04/15/21 04/15 09:30 04/15/21 09:30 $ECON Economic Data / + ShowHide Related Items >><<

Hot Stocks	MasterCard appoints Tim Murphy as chief administrative officer » 09:30 04/15/21 04/15 09:30 04/15/21 09:30 MA MasterCard $378.37 / +0.295 (+0.08%) Mastercard announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MA MasterCard $378.37 / +0.295 (+0.08%) 04/13/21 Gap credit card program in agreements with Barclays and Mastercard 03/23/21 MasterCard expands partnership with Nuvei 03/18/21 L Brands appoints Francis Hondal, Danielle Lee to board of directors 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal MA MasterCard $378.37 / +0.295 (+0.08%) 04/13/21 Morgan Stanley Synchrony loss of Gap card deal 'likely a positive,' says Morgan Stanley 03/19/21 Wells Fargo Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo 03/19/21 Barclays Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays 03/16/21 Morgan Stanley MasterCard price target raised to $412 from $377 at Morgan Stanley MA MasterCard $378.37 / +0.295 (+0.08%) 01/28/21 MasterCard reports Q4 EPS $1.64, consensus $1.51 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 01/25/21 Fly Intel: What to watch in credit card space earnings reports MA MasterCard $378.37 / +0.295 (+0.08%) 03/31/21 MasterCard, rivals colluded on cards for the vulnerable, Reuters reports 03/25/21 MasterCard rejects compound interest on UK class action, Reuters reports 03/23/21 Business payments company AvidXchange preps for IPO, Reuters reports 03/16/21 Visa, MasterCard to delay hikes in card fees for another year, Bloomberg says MA MasterCard $378.37 / +0.295 (+0.08%) 02/12/21 The Intersection: Crypto and Wall Street This Week 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 01/28/21 Fly Intel: Pre-market Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 MasterCard - MA MA MasterCard $378.37 / +0.295 (+0.08%) 04/06/21 Mastercard call volume above normal and directionally bullish 03/24/21 Mastercard call volume above normal and directionally bullish 03/18/21 Mastercard call volume above normal and directionally bullish 02/23/21 Mastercard call volume above normal and directionally bullish
Periodicals	Syneos could be CRO 'target still standing when music stops,' Dealreporter says » 09:29 04/15/21 04/15 09:29 04/15/21 09:29 SYNH Syneos Health $79.53 / +0.68 (+0.86%) , TMO Thermo Fisher $477.68 / -7.13 (-1.47%) , PPD PPD $42.65 / +4.3 (+11.21%) , ICLR Icon $196.37 / -1.44 (-0.73%) After Thermo Fisher (TMO)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events SYNH TMO PPD ICLR SYNH Syneos Health $79.53 / +0.68 (+0.86%) 03/29/21 Syneos Health partners with Science 37 for decentralized clinical trial delivery 02/24/21 Syneos, Protocol First partner to accelerate collection, review of trial data 12/18/20 Syneos Health acquires Illingworth Research Group, terms not disclosed 12/10/20 Syneos Health completes acquisition of Synteract TMO Thermo Fisher $477.68 / -7.13 (-1.47%) 07:04 Today Thermo Fisher to acquire PPD, Inc. for $47.50 per share 07:01 Today Thermo Fisher to acquire PPD, Inc. for $47.50 per share 04/12/21 Thermo Fisher: FDA grants EUA for high-throughput COVID-19 Test 03/24/21 Thermo Fisher to offer integrated COVID-19 testing to U.S. school districts PPD PPD $42.65 / +4.3 (+11.21%) 07:04 Today Thermo Fisher to acquire PPD, Inc. for $47.50 per share 07:01 Today Thermo Fisher to acquire PPD, Inc. for $47.50 per share 04/14/21 PPD trading resumes 04/14/21 PPD trading halted, volatility trading pause ICLR Icon $196.37 / -1.44 (-0.73%) 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/24/21 Icon to acquire PRA Health in $12B cash and stock transaction 02/16/21 Icon provided update on its CYTO-200 portfolio of clinical programs 01/04/21 Icon provides trial services to Pfizer, BioNTech COVID-19 vaccine program SYNH TMO PPD ICLR SYNH Syneos Health $79.53 / +0.68 (+0.86%) 03/02/21 Barclays Syneos Health initiated with an Equal Weight at Barclays 03/02/21 Barclays Syneos Health initiated with an Equal Weight at Barclays 02/22/21 Mizuho Syneos Health price target raised to $87 from $72 at Mizuho 02/19/21 Citi Syneos Health price target raised to $85 from $80 at Citi TMO Thermo Fisher $477.68 / -7.13 (-1.47%) 06:53 Today Citi Thermo Fisher deal for PPD would make sense, says Citi 03/29/21 UBS Thermo Fisher price target lowered to $560 from $588 at UBS 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc PPD PPD $42.65 / +4.3 (+11.21%) 09:17 Today Baird PPD downgraded to Neutral from Outperform at Baird 06:53 Today Citi Thermo Fisher deal for PPD would make sense, says Citi 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays ICLR Icon $196.37 / -1.44 (-0.73%) 04/13/21 BofA Icon resumed with a Neutral at BofA 04/01/21 Wells Fargo Icon upgraded to Overweight from Equal Weight at Wells Fargo 04/01/21 Wells Fargo Icon upgraded to Overweight from Equal Weight at Wells Fargo 03/19/21 Mizuho PRA Health price target raised to $155 from $110 at Mizuho SYNH TMO PPD ICLR SYNH Syneos Health $79.53 / +0.68 (+0.86%) 02/18/21 Syneos Health sees FY21 adjusted EPS $4.09-$4.38, consensus $4.23 02/18/21 Syneos Health reports Q4 adjusted EPS $1.11, consensus $1.10 10/29/20 Syneos Health raises FY20 adjusted EPS view to $3.33-$3.46 from $3.16-$3.38 10/29/20 Syneos Health reports Q3 adjusted EPS $1.04, consensus 91c TMO Thermo Fisher $477.68 / -7.13 (-1.47%) 02/01/21 Thermo Fisher sees FY21 EPS $21.62, consensus $20.74 02/01/21 Thermo Fisher reports Q4 adjusted EPS $7.09, consensus $6.56 12/01/20 Thermo Fisher raises FY20 adjusted EPS view to $19.17, consensus $18.34 10/21/20 Thermo Fisher sees FY20 EPS $18.27, consensus $15.92 PPD PPD $42.65 / +4.3 (+11.21%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B ICLR Icon $196.37 / -1.44 (-0.73%) 02/24/21 Icon sees FY21 adjusted EPS $8.10-$8.50, consensus $7.94 02/24/21 Icon reports Q4 adjusted EPS $1.90, consensus $1.83 10/21/20 Icon raises FY20 revenue view to $6.35-$6.50 from $6.00-$6.50 10/21/20 Icon reports Q3 EPS $1.72, consensus $1.53 01 Mar 02 Dec 17 Sep 16 Sep TMO PPD TMO Thermo Fisher $477.68 / -7.13 (-1.47%) 04/14/21 Thermo Fisher near deal to buy PPD for over $15B, WSJ reports 04/14/21 PPD jumps 13% after report of Thermo Fisher takeover talks 04/14/21 Thermo Fisher near deal to buy drug-testing company PPD for over $15B, WSJ says 02/08/21 Quidel weighs combining with Qiagen, Bloomberg reports PPD PPD $42.65 / +4.3 (+11.21%) 04/14/21 Thermo Fisher near deal to buy PPD for over $15B, WSJ reports 04/14/21 PPD jumps 13% after report of Thermo Fisher takeover talks TMO PPD ICLR TMO Thermo Fisher $477.68 / -7.13 (-1.47%) 02/01/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 10/21/20 Fly Intel: Pre-market Movers PPD PPD $42.65 / +4.3 (+11.21%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein ICLR Icon $196.37 / -1.44 (-0.73%) 02/24/21 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 PPD - PPD 04/29/21 Syneos Health - SYNH 04/29/21 Thermo Fisher - TMO 04/29/21 Icon - ICLR 04/23/21 PPD, Inc. 05/19/21 Thermo Fisher Scientific Inc.
Hot Stocks	Clover Health appoints Demetrios Kouzakas to board of directors » 09:29 04/15/21 04/15 09:29 04/15/21 09:29 CLOV Clover Health $7.43 / -0.38 (-4.87%) Clover Health Investments… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options CLOV Clover Health $7.43 / -0.38 (-4.87%) 04/08/21 Clover Health listed by CMS among DCEs participating in PY21 GPDC model 03/04/21 Clover Health, Mass. General secure grant from National Institute of Health 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/05/21 Palihapitiya calls Hindenburg's comments on Clover 'spurious' CLOV Clover Health $7.43 / -0.38 (-4.87%) 03/09/21 Credit Suisse Clover Health initiated with a Neutral at Credit Suisse 03/03/21 Citi Clover Health price target lowered to $13 from $19 at Citi 02/02/21 Fly Intel: Top five analyst initiations 02/02/21 Citi Clover Health initiated with a Buy at Citi CLOV Clover Health $7.43 / -0.38 (-4.87%) 02/05/21 Hindenburg, in Clover response, says regular investors shouldn't be last to know CLOV Clover Health $7.43 / -0.38 (-4.87%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday CLOV Clover Health $7.43 / -0.38 (-4.87%) 04/09/21 Unusually active option classes on open April 9th 04/09/21 Clover Health call buyer realizes 490% same-day gains 04/08/21 Clover Health call volume above normal and directionally bullish 03/22/21 Largest borrow rate increases among liquid names
Downgrade	New Residential downgraded to Hold from Buy at JonesTrading » 09:29 04/15/21 04/15 09:29 04/15/21 09:29 NRZ New Residential $10.38 / -0.545 (-4.99%) JonesTrading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options NRZ New Residential $10.38 / -0.545 (-4.99%) 04/14/21 New Residential to acquire Caliber Home Loans 02/16/21 New Residential announces $200M share repurchase program 12/17/20 New Residential boosts Q4 dividend by 33% to 20c from 15c 11/20/20 New Residential jumps after NewRez files for initial public offering NRZ New Residential $10.38 / -0.545 (-4.99%) 03/26/21 Credit Suisse Credit Suisse lowers estimates on mortgage originators 03/25/21 RBC Capital New Residential initiated with an Outperform at RBC Capital 02/16/21 Piper Sandler New Residential price target raised to $11 from $10 at Piper Sandler 12/18/20 Keefe Bruyette New Residential upgraded to Outperform from Market Perform at Keefe Bruyette NRZ New Residential $10.38 / -0.545 (-4.99%) 02/09/21 New Residential reports Q4 core EPS 32c, consensus 33c 10/26/20 New Residential reports Q3 core EPS 31c, consensus 38c 15 Apr NRZ New Residential $10.38 / -0.545 (-4.99%) 01/24/21 Opening Day: Mytheresa raises $407M in U.S. market debut 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market 12/27/20 Opening Day: Inhibikase falls below IPO price in first trading day 12/20/20 Opening Day: Upstart, Wish make trading debuts 05/27/21 New Residential Investment Corp. NRZ New Residential $10.38 / -0.545 (-4.99%) 02/26/21 New Residential put volume heavy and directionally bearish 02/09/21 Unusually active option classes on open February 9th 01/28/21 New Residential call volume above normal and directionally bullish 11/20/20 New Residential call volume above normal and directionally bullish
Hot Stocks	Legion files proxy statement and issues letter to OneSpan shareholders » 09:29 04/15/21 04/15 09:29 04/15/21 09:29 OSPN OneSpan $26.54 / -0.34 (-1.26%) Legion Partners Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events OSPN OneSpan $26.54 / -0.34 (-1.26%) 08:57 Today Sidoti OneSpan upgraded to Buy from Neutral at Sidoti 03/31/21 DA Davidson OneSpan initiated with a Buy at DA Davidson as revenue growth accelerates 03/30/21 DA Davidson OneSpan initiated with a Buy at DA Davidson 02/19/21 Sidoti OneSpan downgraded to Neutral from Buy at Sidoti OSPN OneSpan $26.54 / -0.34 (-1.26%) 02/23/21 OneSpan sees FY21 revenue $215M-$225M, consensus $225.1M 02/23/21 OneSpan reports Q4 EPS 3c, consensus 1c 11/02/20 OneSpan sees FY20 revenue $203M-$207M, consensus $233.68M 11/02/20 OneSpan reports Q3 EPS 3c, consensus 5c OSPN OneSpan $26.54 / -0.34 (-1.26%) 11/02/20 Fly Intel: After-Hours Movers 05/04/21 OneSpan - OSPN

Hot Stocks	Hop-on begins integration testing, certification of DigitalAge features » 09:28 04/15/21 04/15 09:28 04/15/21 09:28 HPNN Hop-on, Inc. / + Hop-on has begun… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	CleanSpark purchases 22,680 additional bitcoin miners » 09:28 04/15/21 04/15 09:28 04/15/21 09:28 CLSK CleanSpark $21.28 / -0.47 (-2.16%) CleanSpark has secured… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CLSK CleanSpark $21.28 / -0.47 (-2.16%) 03/26/21 CleanSpark acquires bitcoin mining equipment, infrastructure 03/23/21 CleanSpark provides sales update after acquisition of Solar Watt Solutions 03/09/21 CleanSpark acquires 1,150 new miners capable of producing 100 PH/s 02/09/21 CleanSpark provides acquisition update on Bitcoin mining operations CLSK CleanSpark $21.28 / -0.47 (-2.16%) 03/10/21 BTIG CleanSpark initiated with a Buy at BTIG 03/10/21 BTIG CleanSpark initiated with a Buy at BTIG 02/16/21 H.C. Wainwright CleanSpark price target raised to $50 from $24 at H.C. Wainwright 12/11/20 H.C. Wainwright CleanSpark price target raised to $24 from $18 at H.C. Wainwright CLSK CleanSpark $21.28 / -0.47 (-2.16%) 10/21/20 CleanSpark backs FY21 revenue view $20M, consensus $22.87M 10/21/20 CleanSpark sees FY20 revenue over $10.0M, one estimate $10.22M 16 Mar 07 Oct CLSK CleanSpark $21.28 / -0.47 (-2.16%) 01/14/21 Culper Research issues short report on CleanSpark, calls stock 'uninvestible' CLSK CleanSpark $21.28 / -0.47 (-2.16%) 03/16/21 Fly Intel: Pre-market Movers 03/15/21 Fly Intel: After-Hours Movers 03/12/21 The Intersection: Crypto and Wall Street This Week 01/22/21 The Intersection: Crypto and Wall Street This Week CLSK CleanSpark $21.28 / -0.47 (-2.16%) 02/18/21 CleanSpark call volume above normal and directionally bullish 01/29/21 CleanSpark call volume above normal and directionally bullish 01/11/21 Largest borrow rate increases among liquid names 12/10/20 CleanSpark call volume above normal and directionally bullish
Hot Stocks	CytoDyn enters supply, distribution agreement with Chiral Pharma » 09:27 04/15/21 04/15 09:27 04/15/21 09:27 CYDY CytoDyn $2.85 / -0.14 (-4.68%) CytoDyn announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CYDY CytoDyn $2.85 / -0.14 (-4.68%) 04/07/21 CytoDyn delivers leronlimab to Philippine hospital for COVID-19 patients 04/07/21 CytoDyn signs distribution agreement with Biomm in Brazil for leronlimab 04/05/21 CytoDyn: First CSP patient 'improved significantly' after 700 mg of Vyrologix 04/01/21 CytoDyn files protocol with FDA for leronlimab in critical COVID-19 patients CYDY CytoDyn $2.85 / -0.14 (-4.68%) 04/06/21 CytoDyn to host conference call 04/06/21 CytoDyn to host conference call 07/06/20 H.C. Wainwright CytoDyn downgraded to Neutral from Buy at H.C. Wainwright 04/28/20 H.C. Wainwright CytoDyn price target raised to $4 from $3 at H.C. Wainwright
General news	FX Action: USD-CAD » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 $ECON Economic Data / + FX Action: USD-CAD hit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
General news	U.S. industrial production rebounded 1.4% in March » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 $ECON Economic Data / + U.S. industrial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<

Conference/Events	Jefferies personal/household analyst to hold analyst/industry conference call » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 Personal & Household… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	Goldman Sachs utilities analysts to hold analyst/industry conference call » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 Utilities Analysts Kim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 WDAY Workday $259.65 / -6.11 (-2.30%) , NKE Nike $132.24 / -1.23 (-0.92%) Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WDAY NKE WDAY Workday $259.65 / -6.11 (-2.30%) 04/06/21 Workday announces new capabilities for Workday Extend 03/09/21 Workday completes acquisition of Peakon 02/26/21 Workday sees FY22 subscription revenue at $4.38B-$4.40B, up 16% y/y 02/24/21 Workday appoints Lynne Doughtie to board of directors NKE Nike $132.24 / -1.23 (-0.92%) 03/25/21 Nike slides amid reports of possible China boycotts related to Xinjiang 03/18/21 Nike down 2.5% below $140 per share after Q3 results, Q4 earnings call guidance 03/18/21 Nike says exceeding pre-pandemic levels of business when looking out to FY22 03/18/21 Nike CFO says EMEA inventory to be normalized by Q1 of 2022 if pandemic eases WDAY NKE WDAY Workday $259.65 / -6.11 (-2.30%) 03/17/21 Canaccord Workday price target raised to $300 from $265 at Canaccord 03/15/21 Credit Suisse Workday assumed with a Neutral at Credit Suisse 03/09/21 JPMorgan Workday added to Analyst Focus List at JPMorgan 03/08/21 Morgan Stanley Software industry rating raised to Attractive from In-Line at Morgan Stanley NKE Nike $132.24 / -1.23 (-0.92%) 03/31/21 HSBC Nike price target raised to $162 from $158 at HSBC 03/30/21 Oppenheimer Nike's China issues likely to resolve, says Oppenheimer 03/26/21 Fly Intel: Top five analyst upgrades 03/26/21 Baird Baird upgrades Nike after two years, sees concerns as temporary WDAY NKE WDAY Workday $259.65 / -6.11 (-2.30%) 02/25/21 Workday reports Q4 EPS 73c, consensus 55c 02/25/21 Notable companies reporting after market close 11/19/20 Workday ups FY21 subscription revenue view to $3.77B-$3.78B from $3.73B-$3.74B 11/19/20 Workday reports Q3 EPS 86c, consensus 67c NKE Nike $132.24 / -1.23 (-0.92%) 03/18/21 Nike CFO sees Q4 revenue growth up 75% from last year, consensus $10.37B 03/18/21 Nike reports Q3 EPS 90c, consensus 76c 03/18/21 Notable companies reporting after market close 12/18/20 Nike raises FY21 revenue growth view to low teens NKE NKE Nike $132.24 / -1.23 (-0.92%) 04/08/21 Nike, MSCHF resolve legal battle over 'Satan Shoes,' Yahoo Finance says 04/07/21 Nike suspends endorsement of Deshaun Watson over misconduct claims, CNBC says 04/05/21 Study finds 55% of U.S. largest companies paid no taxes in 2020, NY Times report 03/30/21 Nike files patent infringement suit against MSCHF for 'Satan' shoes, WSJ reports WDAY NKE WDAY Workday $259.65 / -6.11 (-2.30%) 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 02/25/21 Fly Intel: After-Hours Movers 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street NKE Nike $132.24 / -1.23 (-0.92%) 03/26/21 Nike, Altria upgrades among today's top calls on Wall Street 03/25/21 Fly Intel: Wall Street's Top Stories for Thursday 03/25/21 Fly Intel: Wall Street's top stories at midday 03/19/21 Fly Intel: Wall Street's top stories for Friday 10:00 Today Software & Internet 06/08/21 Workday, Inc. WDAY NKE WDAY Workday $259.65 / -6.11 (-2.30%) 02/25/21 Workday put volume heavy and directionally bearish 11/19/20 Workday options imply 7.7% move in share price post-earnings NKE Nike $132.24 / -1.23 (-0.92%) 03/26/21 Unusually active option classes on open March 26th 03/25/21 Nike put volume heavy and directionally bearish 03/25/21 Unusually active option classes on open March 25th 03/18/21 Nike options imply 6.9% move in share price post-earnings
Conference/Events	REV Group to host virtual investor meeting » 09:25 04/15/21 04/15 09:25 04/15/21 09:25 REVG REV Group $18.85 / +0.155 (+0.83%) Virtual Investor Meeting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events REVG REV Group $18.85 / +0.155 (+0.83%) 03/30/21 REV Group rises 9.8% 03/29/21 REV Group jumps over 3% to $18.30 after disclosed insider buying 03/29/21 REV Group CEO buys 16.8K shares of common stock 01/15/21 REV Group CFO buys 15K shares of common stock REVG REV Group $18.85 / +0.155 (+0.83%) 03/12/21 BMO Capital REV Group price target raised to $19 from $10 at BMO Capital 03/11/21 Morgan Stanley REV Group price target raised to $18 from $10 at Morgan Stanley 03/10/21 Baird REV Group price target raised to $22 from $20 at Baird 03/10/21 Baird REV Group continues to benefit from stimulus funding, says Baird REVG REV Group $18.85 / +0.155 (+0.83%) 03/10/21 REV Group sees FY21 revenue $2.45B-$2.6B, consensus $2.36B 03/10/21 REV Group reports Q1 adjusted EPS 14c, consensus 6c 01/07/21 REV Group reports Q4 adjusted EPS 19c, consensus 16c 12/17/20 REV Group reports preliminary Q4 revenue $616M, consensus $614.14M REVG REV Group $18.85 / +0.155 (+0.83%) 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 10:00 Today REV Group, Inc.
Recommendations	Ross Stores price target raised to $145 from $130 at Loop Capital » 09:23 04/15/21 04/15 09:23 04/15/21 09:23 ROST Ross Stores $126.90 / +0.43 (+0.34%) Loop Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ROST Ross Stores $126.90 / +0.43 (+0.34%) 03/16/21 Ross Stores chairman Michael Balmuth will not stand for re-election 03/08/21 Ross Stores to open 60 new locations In 2021 03/02/21 Ross Stores falls 5% to $111.50 after Q4 earnings miss 03/02/21 Ross Stores reports Q4 SS down 6% ROST Ross Stores $126.90 / +0.43 (+0.34%) 03/18/21 Deutsche Bank Ross Stores named 'Short-Term Catalyst Buy' at Deutsche Bank 03/05/21 Evercore ISI Burlington Stores price target raised to $290 from $225 at Evercore ISI 03/05/21 UBS Ross Stores price target lowered to $120 from $125 at UBS 01/21/21 Deutsche Bank Ross Stores price target raised to $129 from $123 at Deutsche Bank ROST Ross Stores $126.90 / +0.43 (+0.34%) 03/02/21 Ross Stores sees Q1 EPS 74c-86c, consensus 89c 03/02/21 Ross Stores reports Q4 EPS 67c, consensus $1.00 11/19/20 Ross Stores says November month-to-date comps down mid-single-digits 11/19/20 Ross Stores reports Q3 EPS $1.02 excluding 65c charge, consensus 61c ROST Ross Stores $126.90 / +0.43 (+0.34%) 02/27/21 Ross Stores stock 'a unique bargain' among discount retailers, Barron's says ROST Ross Stores $126.90 / +0.43 (+0.34%) 03/02/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: After-Hours Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 05/19/21 Ross Stores, Inc. ROST Ross Stores $126.90 / +0.43 (+0.34%) 03/08/21 Early notable gainers among liquid option names on March 8th 11/20/20 Early notable gainers among liquid option names on November 20th 11/19/20 Ross Stores options imply 4.2% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

WIT
Today at 09:45

Wipro - WIT Conference Calls
Today at 10:00

Business Inventories M/M: February 2021 Government Event
Today at 10:00

Housing Market Index: April 2021 Government Event
Today at 10:00

Cellular, Tissue & Gene Therapies Advisory Committee Meeting Government Event

Virtual Meeting
KLXE
Today at 10:00

KLX Energy - KLXE Conference Calls
DAL
Today at 10:00

Delta Air Lines - DAL Conference Calls
CVAC
Today at 10:00

CureVac - CVAC Conference Calls
C
Today at 10:00

Citi - C Conference Calls
FMNB
Today at 10:00

Farmers National Banc Corp Firm Sponsored Meetings
DGICB
Today at 10:00

Donegal Group Inc. CL B Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Piper's teen survey shows declining Facebook engagement

TODAY'S FREE FLY STORIES

Get Full Fly Access